← boothcheck

Is THG overvalued?

boothcheck doesn't label THG overvalued or undervalued, and it doesn't publish a fair value. It shows what the price assumes instead. At today's price, THG is priced for growth of +13.7%. The price is supported by asset-based and earnings-power and relative-multiple value. A value/asset-supported name, not a pure growth bet. The more the price assumes beyond what HANOVER INSURANCE GROUP, INC. has actually delivered, the more has to go right to justify it. Whether that bar is too high is your call, and the full bull and bear cases are in the report.

Derived from HANOVER INSURANCE GROUP, INC.'s SEC EDGAR filings via a reverse-DCF inversion. Last analyzed July 11, 2026.

Implied growth+13.7%
For about
Margin needed
Margin today
Price vs asset value1.00x
Price vs earnings power0.67x
Price vs peer multiples0.87x
Price vs forward growth1.26x
Read the full THG report →
Get boothcheck's read on what THG's price is betting on, in your inbox when it moves. No hype, no spam.
Free. Informational only, not investment advice. Unsubscribe anytime.

For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.